User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 02:16, 10 September 2023 (diff | hist) . . (-5,795) . . Part:BBa K4156078 (Replaced content with " __NOTOC__ <partinfo>BBa_K4156078 short</partinfo> <!-- Add more about the biology of this part here --> </i> <span class='h3bb'>Sequence and Features</span> <parti...") (current)
- 02:13, 10 September 2023 (diff | hist) . . (-944) . . Part:BBa K4156078:Design (current)
- 07:51, 13 October 2022 (diff | hist) . . (-2) . . Part:BBa K4156104 (current)
- 07:50, 13 October 2022 (diff | hist) . . (0) . . Part:BBa K4156104 (→Lactate (pLldR) and pH (pCadC) Induced promoter-controlled effector engineered strain co-incubated with RKO cells)
- 07:43, 13 October 2022 (diff | hist) . . (+328) . . Part:BBa K4156101 (current)
- 07:39, 13 October 2022 (diff | hist) . . (0) . . Part:BBa K4156078 (→Applications)
- 07:39, 13 October 2022 (diff | hist) . . (+2) . . Part:BBa K4156109 (current)
- 07:38, 13 October 2022 (diff | hist) . . (0) . . Part:BBa K4156108 (current)
- 07:33, 13 October 2022 (diff | hist) . . (+10) . . Part:BBa K4156076 (current)
- 07:31, 13 October 2022 (diff | hist) . . (0) . . Part:BBa K4156099 (current)
- 07:29, 13 October 2022 (diff | hist) . . (0) . . Part:BBa K4156099 (→30 μl effector engineered strains (OD=0.6) were co-incubated with RKO cells for different times)
- 07:29, 13 October 2022 (diff | hist) . . (+1) . . Part:BBa K4156099 (→Coincubation of different doses of effector engineered strains (OD=0.6) with RKO cells)
- 07:28, 13 October 2022 (diff | hist) . . (0) . . Part:BBa K4156099 (→Lactate (pLldR) and pH (pCadC) Induced promoter-controlled effector engineered strain co-incubated with RKO cells)
- 07:27, 13 October 2022 (diff | hist) . . (+1) . . Part:BBa K4156076 (→Better Chassis)
- 07:25, 13 October 2022 (diff | hist) . . (+3) . . Part:BBa K4156076 (→Addition of lysis genes)
- 07:24, 13 October 2022 (diff | hist) . . (0) . . Part:BBa K4156099 (→In vitro characterization and data analysis of the reported strains)
- 07:24, 13 October 2022 (diff | hist) . . (0) . . Part:BBa K4156108 (→In vitro characterization and data analysis of the reported strains)
- 07:23, 13 October 2022 (diff | hist) . . (0) . . Part:BBa K4156076 (→Stability improvement)
- 07:23, 13 October 2022 (diff | hist) . . (+1,661) . . Part:BBa K4156104 (→In vitro characterization and data analysis of the reported strains)
- 07:22, 13 October 2022 (diff | hist) . . (0) . . Part:BBa K4156104 (→In vitro characterization and data analysis of the reported strains)
- 07:22, 13 October 2022 (diff | hist) . . (0) . . Part:BBa K4156101 (→Stability improvement)
- 07:21, 13 October 2022 (diff | hist) . . (+1,661) . . Part:BBa K4156101 (→Stability improvement)
- 07:19, 13 October 2022 (diff | hist) . . (+1) . . Part:BBa K4156104 (→Coincubation of different doses of effector engineered strains (OD=0.6) with RKO cells)
- 07:18, 13 October 2022 (diff | hist) . . (+845) . . Part:BBa K4156108 (→In vitro characterization and data analysis of the reported strains)
- 07:18, 13 October 2022 (diff | hist) . . (+845) . . Part:BBa K4156099 (→In vitro characterization and data analysis of the reported strains)
- 07:18, 13 October 2022 (diff | hist) . . (+845) . . Part:BBa K4156104 (→In vitro characterization and data analysis of the reported strains)
- 07:17, 13 October 2022 (diff | hist) . . (-43) . . Part:BBa K4156101 (→Stability improvement)
- 07:17, 13 October 2022 (diff | hist) . . (-44) . . Part:BBa K4156076 (→Stability improvement)
- 07:16, 13 October 2022 (diff | hist) . . (+889) . . Part:BBa K4156076 (→Stability improvement)
- 07:12, 13 October 2022 (diff | hist) . . (0) . . Part:BBa K4156101 (→Initial Testing of lactate Promoter)
- 07:12, 13 October 2022 (diff | hist) . . (+889) . . Part:BBa K4156101 (→Stability improvement)
- 07:19, 12 October 2022 (diff | hist) . . (0) . . Part:BBa K4156114 (→lactate induced promoter testing) (current)
- 07:18, 12 October 2022 (diff | hist) . . (0) . . Part:BBa K4156101 (→Initial Testing of lactate Promoter)
- 07:13, 12 October 2022 (diff | hist) . . (+1,518) . . Part:BBa K4156078
- 06:23, 12 October 2022 (diff | hist) . . (-75) . . Part:BBa K4156110 (→hypoxia induced promoter testing) (current)
- 06:22, 12 October 2022 (diff | hist) . . (-541) . . Part:BBa E1010 (→Contribution) (current)
- 02:51, 12 October 2022 (diff | hist) . . (0) . . Part:BBa K4156113 (→Characterization) (current)
- 02:50, 12 October 2022 (diff | hist) . . (+410) . . Part:BBa K4156113 (→Characterization)
- 02:44, 12 October 2022 (diff | hist) . . (+406) . . Part:BBa K1847001:Experience (→Characterization and Improvement by LZU-CHINA iGEM 2022) (current)
- 02:04, 12 October 2022 (diff | hist) . . (+1) . . Part:BBa K4156118 (→Characterization) (current)
- 01:59, 12 October 2022 (diff | hist) . . (0) . . Part:BBa K4156119 (current)
- 01:57, 12 October 2022 (diff | hist) . . (-274) . . Part:BBa K4156101
- 01:55, 12 October 2022 (diff | hist) . . (+1,518) . . Part:BBa K4156076
- 01:53, 12 October 2022 (diff | hist) . . (-1,474) . . Part:BBa K4156076 (→Addition of lysis genes)
- 01:53, 12 October 2022 (diff | hist) . . (-1,476) . . Part:BBa K4156105 (→Western blot) (current)
- 01:50, 12 October 2022 (diff | hist) . . (+10,426) . . Part:BBa K4156101 (→Addition of lysis genes)
- 01:50, 12 October 2022 (diff | hist) . . (+1,476) . . Part:BBa K4156105
- 01:48, 12 October 2022 (diff | hist) . . (-5) . . Part:BBa K4156104 (→In vitro characterization and data analysis of the reported strains)
- 01:48, 12 October 2022 (diff | hist) . . (+1,953) . . Part:BBa K4156101 (→Stability improvement)
- 01:47, 12 October 2022 (diff | hist) . . (+729) . . Part:BBa K4156101 (→Initial Testing of lactate Promoter)
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)